NCT07224906 Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
| NCT ID | NCT07224906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HemoCept Inc. |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-12-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Eligibility Criteria
Inclusion Criteria: * Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. * Subjects can be any gender but must be age 18 or older. * Subject is able and willing to provide informed consent and HIPAA authorization. * Subject is able and willing to meet all study requirements. * Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible) Exclusion Criteria: * Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07224906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07224906 currently recruiting?
Yes, NCT07224906 is actively recruiting participants. Contact the research team at kathari.adkins@bch.org for enrollment information.
Where is the NCT07224906 trial being conducted?
This trial is being conducted at Boulder, United States.
Who is sponsoring the NCT07224906 clinical trial?
NCT07224906 is sponsored by HemoCept Inc.. The trial plans to enroll 50 participants.